FindOwnerSearch
Brands and Their Owners
| 4D PHARMA PLC contact information is shown below | |
| Owner: | 4D PHARMA PLC |
|---|---|
| Owner Address: | 5th Floor, 9 Bond Court Leeds LS12JZ United Kingdom |
| Owner Web Site | |
| Owner Phone | |
| Owner Toll Free | |
| Owner Fax |
| Brand: |
4D |
|---|---|
| Description: | Scientific research and development; microbiology research and development into live biotherapeutics; |
| Category: | SCIENTIFIC RESEARCH DEVELOPMENT |
| Brand: |
4D |
|---|---|
| Description: | In the statement, lines 2 and 3 should be deleted and 9 Bond Court should be inserted; and in line 4 Aberdeen should be deleted and Leeds should be inserted and AB252ZS should be deleted and LS1 2JZ should be inserted.;Prescribed pharmaceuticals as live biotherapeutics for the treatment of cancer, central nervous system diseases, and gastrointestinal diseases; live biotherapeutic pharmaceuticals for the treatment of inflammatory and autoimmune diseases; pharmaceuticals, namely, live biotherapeutic bacterial formulations for medical use for the treatment of cancer, central nervous system diseases, gastrointestinal diseases, and inflammatory and autoimmune diseases; lyophilized formulations of microorganisms for medical use; |
| Category: | STATEMENT |
| Brand: |
BLAUTIX |
|---|---|
| Description: | In the statement, lines 2 and 3 should be deleted and 9 Bond Court should be inserted; and in line 4 Aberdeen should be deleted and Leeds should be inserted and AB252ZS should be deleted and LS1 2JZ should be inserted.;In the statement, line 12, UK0000330825 should be deleted, and UK0003308252 should be inserted.;Pharmaceuticals, namely, live biotherapeutics for the treatment of irritable bowel syndrome (IBS) and intestinal disorders; live biotherapeutic bacterial formulations for medical use, namely, the treatment of irritable bowel syndrome (IBS) and intestinal disorders; preparations of microorganisms for medical use; |
| Category: | STATEMENT |
| Brand: |
DEVELOPING SCIENCE, DELIVERING THERAPIES |
|---|---|
| Description: | pharmaceuticals, namely, live biotherapeutics for the treatment of inflammatory and autoimmune diseases; pharmaceuticals, namely, live biotherapeutics for the treatment of cancer; pharmaceuticals, namely, live biotherapeutics for the treatment of gastrointestinal diseases; pharmaceuticals, namely, live biotherapeutics for the treatment of central nervous system diseases; pharmaceuticals, namely, live biotherapeutic bacterial formulations for medical use for the treatment of cancer, central nervous system diseases, gastrointestinal diseases, and inflammatory and autoimmune diseases; pharmaceutical preparations of microorganisms for medical use for the treatment of cancer, central nervous system diseases, gastrointestinal diseases, and inflammatory and autoimmune diseases;Scientific research and development; pharmaceutical research and development; microbiology research and development into live biotherapeutics; |
| Category: | PHARMACEUTICALS |
| Brand: |
MICRODX |
|---|---|
| Description: | In the statement, lines 2 and 3 should be deleted and 9 Bond Court should be inserted; and in line 4 Aberdeen should be deleted and Leeds should be inserted and AB252ZS should be deleted and LS1 2JZ should be inserted.;MICRO DX;Scientific research and development; microbiology research and development into live biotherapeutics; |
| Category: | STATEMENT |
| Brand: |
MICRORX |
|---|---|
| Description: | In the statement, lines 2 and 3 should be deleted and 9 Bond Court should be inserted; and in line 4 Aberdeen should be deleted and Leeds should be inserted and AB252ZS should be deleted and LS1 2JZ should be inserted.;MICRO RX;Scientific research and development; Microbiology research and development into live biotherapeutics; |
| Category: | STATEMENT |
| Brand: |
MRX |
|---|---|
| Description: | In the statement, lines 2 and 3 should be deleted and 9 Bond Court should be inserted; and in line 4 Aberdeen should be deleted and Leeds should be inserted and AB252ZS should be deleted and LS1 2JZ should be inserted.;Pharmaceuticals, namely, live biotherapeutics for the treatment of cancer, brain injuries, central nervous system disorders, bowel disorders, lung disorders and diseases, and inflammatory and autoimmune diseases; live biotherapeutic bacterial formulations for medical use, namely, the treatment of cancer, brain injuries, central nervous system disorders, bowel disorders, lung disorders and diseases, and inflammatory and autoimmune diseases; preparations of microorganisms for medical use; |
| Category: | STATEMENT |
| Brand: |
THETANIX |
|---|---|
| Description: | In the statement, line 11, UK0000331162 should be deleted, and UK0003311622 should be inserted.;Pharmaceuticals, namely, live biotherapeutics for the treatment of Crohn's disease and bowel diseases; live biotherapeutic bacterial formulations for medical use, namely, the treatment of Crohn's disease and bowel diseases; preparations of microorganisms for medical use;In the statement, lines 2 and 3 should be deleted and 9 Bond Court should be inserted; and in line 4 Aberdeen should be deleted and Leeds should be inserted and AB252ZS should be deleted and LS1 2JZ should be inserted.; |
| Category: | STATEMENT |